ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	20/168	157/7206	4.46761401289e-10
ko04380	Osteoclast differentiation	18/168	134/7206	1.47478420112e-09
ko04060	Cytokine-cytokine receptor interaction	21/168	191/7206	2.49439910202e-09
ko05164	Influenza A	19/168	167/7206	8.59670294785e-09
ko04064	NF-kappa B signaling pathway	14/168	96/7206	3.70979876107e-08
ko04620	Toll-like receptor signaling pathway	14/168	100/7206	6.31764898948e-08
ko05321	Inflammatory bowel disease (IBD)	10/168	56/7206	5.12255024043e-07
ko05162	Measles	14/168	120/7206	6.38500839317e-07
ko04217	Necroptosis	17/168	178/7206	7.0726951525e-07
ko04660	T cell receptor signaling pathway	14/168	124/7206	9.56848880773e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	17/168	191/7206	1.9048535657e-06
ko04650	Natural killer cell mediated cytotoxicity	12/168	97/7206	2.22542832349e-06
ko05161	Hepatitis B	16/168	173/7206	2.34670825909e-06
ko04630	Jak-STAT signaling pathway	13/168	132/7206	1.09535642935e-05
ko05160	Hepatitis C	13/168	153/7206	5.32251626459e-05
ko04658	Th1 and Th2 cell differentiation	10/168	96/7206	7.26882920695e-05
ko05168	Herpes simplex infection	14/168	182/7206	8.17134377578e-05
ko04622	RIG-I-like receptor signaling pathway	8/168	62/7206	8.55022894636e-05
ko04668	TNF signaling pathway	11/168	120/7206	0.000102750031198
ko05152	Tuberculosis	14/168	187/7206	0.000109455932424
ko05145	Toxoplasmosis	11/168	126/7206	0.000159414437826
ko04662	B cell receptor signaling pathway	9/168	88/7206	0.000193450480048
ko05323	Rheumatoid arthritis	9/168	89/7206	0.000210971841402
ko05140	Leishmaniasis	8/168	75/7206	0.00032996560682
ko04664	Fc epsilon RI signaling pathway	8/168	77/7206	0.000395614593919
ko05144	Malaria	6/168	45/7206	0.000562866351228
ko05133	Pertussis	8/168	87/7206	0.000902070083085
ko04210	Apoptosis	12/168	180/7206	0.000971983444647
ko05166	HTLV-I infection	16/168	292/7206	0.0012296160078
ko04611	Platelet activation	11/168	163/7206	0.00142994276941
ko04672	Intestinal immune network for IgA production	5/168	37/7206	0.00154600467086
ko05134	Legionellosis	7/168	74/7206	0.00159942764226
ko04666	Fc gamma R-mediated phagocytosis	9/168	122/7206	0.00210253447134
ko04623	Cytosolic DNA-sensing pathway	5/168	41/7206	0.0024659568557
ko04062	Chemokine signaling pathway	12/168	201/7206	0.00249331665026
ko04142	Lysosome	10/168	151/7206	0.00269006680493
ko04659	Th17 cell differentiation	8/168	106/7206	0.00320519885959
ko04080	Neuroactive ligand-receptor interaction	2/168	423/7206	0.00424336279501
ko04145	Phagosome	10/168	162/7206	0.00445968211343
ko05340	Primary immunodeficiency	4/168	30/7206	0.00486665847159
ko05132	Salmonella infection	7/168	98/7206	0.00772373105874
ko05150	Staphylococcus aureus infection	4/168	36/7206	0.00938902234405
ko04610	Complement and coagulation cascades	6/168	79/7206	0.0100331043479
ko05142	Chagas disease (American trypanosomiasis)	8/168	130/7206	0.0107992005811
ko05131	Shigellosis	6/168	82/7206	0.0119405261184
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/168	135/7206	0.0133612738997
ko04917	Prolactin signaling pathway	6/168	87/7206	0.0156656420049
ko05330	Allograft rejection	3/168	24/7206	0.0175843509344
ko05418	Fluid shear stress and atherosclerosis	9/168	173/7206	0.0195490755561
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/168	92/7206	0.0201288099772
ko04670	Leukocyte transendothelial migration	8/168	151/7206	0.0245500319522
ko05169	Epstein-Barr virus infection	10/168	206/7206	0.0291666250746
ko04612	Antigen processing and presentation	5/168	77/7206	0.0333684315255
ko04070	Phosphatidylinositol signaling system	6/168	112/7206	0.0464074964911